-
Gennova’s mRNA vaccine to come in powder form
Gennova’s mRNA remains stable at 2-8 degrees C. India at present can handle temperature integrity of 2-8 degrees C across the cold chain.
-
Pfizer and AstraZeneca less effective against Delta variant
Delta infections after two vaccine doses had similar peak levels of virus as those in unvaccinated people, the researchers said
-
Talks with foreign vaccine makers stuck on indemnity clause
The foreign vaccine makers are demanding indemnity against legal liability in case of adverse reactions post-vaccination.
-
Covid-19: Vaccination for children to roll out by September
Lancet medical journal has said that living with children aged between 11 and 17 increases the chances of getting infected by 18-30%.
-
Pfizer pushes for a booster dose to fight Delta variant
Pfizer and its partner BioNTech said the studies conducted on people who took the third jab of the original vaccine have shown encouraging results
-
Pfizer in final stages of agreement to supply vaccine: CEO
Pfizer CEO Dr Albert Bourla said that significant local manufacturing of vaccines will provide the “backbone of vaccinating” the Indian people
-
Pfizer, AstraZeneca vaccines protect against Delta variant: Lancet study
Pfizer vaccine offered 92% protection against the Alpha variant and 79% against the Delta strain two weeks after the second dose.
-
G-7 nations pledge 1 billion vaccine doses for world
G-7 leaders' summit is set to formally embrace a global minimum tax of at least 15% on corporations.
-
US to donate half a billion Pfizer vaccines
The United States has faced increasing pressure to outline its global vaccine sharing pl
-
Centre, Pfizer working together for earliest possible import of vaccine: VK Paul
As soon as Pfizer indicated vaccine availability, the central government and the company are working together for the earliest possible import of the
